Carregando...
CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
CD73 is a glycosylphosphatidylinositol (GPI)‐anchored protein that attenuates tumour immunity via cooperating with CD39 to generate immunosuppressive adenosine. Therefore, CD73 blockade has been incorporated into clinical trials for cancers based on preclinical efficacy. However, the biological role...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7412695/ https://ncbi.nlm.nih.gov/pubmed/32643277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|